Risk of Subsequent Non-germ Cell Cancer After Treatment of Germ Cell Cancer in 2006 Norwegian Male Patients

By Wandera E.H.   Fossa S.D.   Tretli S.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 253-262

Elsevier

Access to resources Recommend Favorite

Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support

By Kollmannsberger C.   Schleucher N.   Rick O.   Metzner B.   Hartmann J.T.   Schoffski P.   Beyer J.   Casper J.   Sosada M.   Schmoll H.-J.   Bohlke I.   Meisner C.   Kanz L.   Bokemeyer C.  

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 775-782

Elsevier

Access to resources Recommend Favorite

Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer

By Kälkner Karl Mikael   Ullén Anders   Wersäll Peter   Cohn-Cedermark Gabriella  

Acta Oncologica, Vol. 46, Iss. 6, 2007-01 ,pp. : 862-863

Informa Healthcare

Access to resources Recommend Favorite

Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience

By Fukui Naotaka   Kohno Yusuke   Ishioka Jun-Ichiro   Fukuda Hiroshi   Kageyama Yukio   Higashi Yotsuo  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 731-734

Springer Publishing Company

Access to resources Recommend Favorite

Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure?

By Maase Hans Von Der  

Acta Oncologica, Vol. 44, Iss. 6, 2005-09 ,pp. : 523-525

Informa Healthcare

Access to resources Recommend Favorite